<DOC>
	<DOCNO>NCT00630903</DOCNO>
	<brief_summary>The purpose study determine combination PUVA interferon alpha well PUVA alone treat mycosis fungoides stage Ia Ib IIa .</brief_summary>
	<brief_title>PUVA Versus PUVA + IFN Alpha 2a Mycosis Fungoides</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Methoxsalen</mesh_term>
	<criteria>Mycosis fungoides Stage Ia Ib IIa Written inform consent 1870 y.o. , sex No concomitant systemic disease Pregnant lactate woman Fertile woman accept contraception Medical history melanoma non melanoma skin cancer Concomitant infection Immunodeficiency state Previous Heart disease Respiratory insufficiency Chronic RRenal insufficiency Chronic hepatopathy Epilepsy Depression Leucocytes &lt; 3000 neutrophile &lt; 1000 thrombocytes &lt; 100000 hemoglobin &lt; 12 gr/dL ANA &lt; 1/80 Treatment systemic steroid Altered thyroid hormone Previous resistance PUVA and/or IFN Hypersensitivity IFN Patients treatment teophiline and/or dicumarol Previous total skin electron beam Wash period le 3 month IFN /or PUVA Wash period le 1 month topical treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>